期刊文献+

BSA肠溶微囊的制备及释药特性 被引量:1

Preparation and Drug Release Characteristics of Enteric-Coated Microcapsules of BSA
在线阅读 下载PDF
导出
摘要 目的:制备BSA壳聚糖-海藻酸钠肠溶微囊并测试释放特性。方法:以微球的包封率为制备工艺优化指标,利用复凝聚法,通过正交实验筛选微球的最佳制备工艺条件制备微球。结果:最优条件为牛血清白蛋白和海藻酸钠的比例为1:6,壳聚糖的浓度为0.1%(g/ml),氯化钙的浓度为1%(g/ml)以及搅拌时间为1h。结论:BSA微囊在小肠中对蛋白有一定的缓释效果,突释效应不明显。 Objective: To prepare enteric microcapsules of BSA using the chitosan and sodium alginate as the matrix material, to test drug release characteristics. Methods: Complex coacervation was the method of preparation of microcapsules. The ratio of encapsulation acting as the preparation optimization target,the best technology was screened with orthogonal design. Results: The optimum formulation was BSA and Sodium algina chloride concentration of 1% (g/mL) Conclusion: Microcapsules of BSA has not evident. te ratio of 1:6, chitosan concentration of 0.1% (g/mL), calcium and stirring time was lh in the most optimal conditions. some slow-release effect in the small intestine, burst effect were
出处 《金华职业技术学院学报》 2013年第3期89-92,共4页 Journal of Jinhua Polytechnic
关键词 肠溶微囊 牛血清白蛋白 复凝聚法 正交试验 enteric-coated microcapsules, bovine serum albumin (BSA), complex coacervation,orthogonal experimental
  • 相关文献

参考文献4

二级参考文献55

  • 1刘善奎,钟延强,王芳,孙树汉,高申.口蹄疫DNA疫苗海藻酸钠微球的制备及体外释放的研究[J].药学服务与研究,2004,4(2):107-110. 被引量:6
  • 2俞媛,高申.促进药物透皮吸收方法的研究进展[J].中国医药工业杂志,2005,36(2):115-119. 被引量:7
  • 3金城,王海涛,肖小河.蛋白多肽类药物口服给药的研究进展[J].解放军药学学报,2005,21(1):51-54. 被引量:5
  • 4王萍,陈钧.酶抑制剂在蛋白质和肽类药物口服制剂中的应用[J].中国医药工业杂志,2005,36(8):510-514. 被引量:2
  • 5Kofuji K, Isobe T, Murata Y. Controlled release ofalpha-lipoic acid through incorporation into natural polysaccharide-based gel beads [J]. Food Chemistry, 2009, 115(2): 483-487.
  • 6Coppi G, Iannuccelli V. Alginate/chitosan microparticles for tamoxifen delivery to the lymphatic system [J]. Int. J. Pharm., 2009, 367 (1-2):127-132.
  • 7Kumar S, Dwevedi A, Kayastha A M.Immobilization of soybean (Glycine max) urease on alginate and chitosan beads showing improved stability: Analytical applications[J].Journal of Molecular Catalysis B: Enzymatic, 2009, 58(1-4): 138-145.
  • 8Wittaya-areekul S, Kruenate J, Prahsam C. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone[J] Int. J. Pharm., 2006, 312(1-2): 113-118.
  • 9Yapar E, Kayahan S K, Bozkurt A, et al. Immobilizing cholesterol oxidase in chitosan-alginic acid network [J].Carbohydrate Polymers, 2009, 76(3): 430-436.
  • 10Hwang Y S, Cho J, Tay Y, et al. The use ofmurine embryonic stem cells, alginate encapsulation, and rotary microgravity bioreactor in bone tissueengineering [J].Biomaterials, 2009, 30(4): 499-507.

共引文献16

同被引文献17

  • 1郭勇.现代生化技术[M].广州:华南理工大学出版社,1998.48.50.
  • 2唐裕.蛋白多肽类药物的药代动力学研究现状[C].中国药理学会临床药理专业委员会.第十三次全国临床药理学学术大会论文汇编,2012.
  • 3ZHOU S B,DENG X M,YANG H.Bio degradable poly(ε-caprolactone)-poly(ethylene glycol)block copolymers:Characterization and their use as drug carriers for a controlled delivery system[J].Biomaterials,2003,24(20):3563-3570.
  • 4HERBERT P,MURPHY K,JOHNSON O,et al.A large-scale process to produce microencapsulated proteins[J].Pharm Res,1998,15(2):357.
  • 5LIN W J,HUANG L I,CHANG R R.Characterization of protein-loaded poly(ε-caprolactone)microparticles based on a factorial design[J].Journal of Microencapsulation,2001,18(2):183-189.
  • 6张均金.5-氟尿嘧啶—丝素蛋白—壳聚糖微囊制备的研究[D].江苏科技大学,2010.
  • 7王侃,张琰,苄卿卿,郎美东.BSA载药微囊的制备、表征及体外释放行为[J].功能高分子学报,2008,21(4):364-370. 被引量:3
  • 8洪怡,袁开.载药微球制备的研究进展[J].数理医药学杂志,2012,25(3):352-355. 被引量:3
  • 9李盈,娄月芬.蛋白多肽类药物制剂的研究进展[J].现代生物医学进展,2012,12(19):3762-3765. 被引量:6
  • 10金一(综述),余传信(审校).蛋白质及多肽类药物长效化研究进展[J].中国血吸虫病防治杂志,2012,24(5):594-597. 被引量:6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部